Loading
·
Silexion Therapeutics Corp is a developmental-stage company dedicated to the development of treatments for pancreatic cancer. The company is focused on enhancing its first-generation product (LODERTM ) to develop a newly formulated product to improve the clinical efficacy against pancreatic cancer.
The quarterly reports for this company are not available yet. Please check back later.
In the mean time, check out some related stocks.